Orchestra BioMed Holdings, Inc.

Orchestra BioMed Holdings, Inc. - ROEverified

OBIO

Price:

$3.99

Market Cap:

$238.92M

Orchestra BioMed Holdings, Inc. operates as an innovative company in the biomedical sector. Its leading product candidates are BackBeat Cardiac Neuromodulation Therapy (CNT), designed to manage hypertension, and the Virtue Sirolimus AngioInfusion Balloon (SAB), aimed at treating atherosclerotic artery disease. The company's offerings also encompass FreeHold retractors, which are solutions for minimally invasive surgical procedures. Orchestra BioMed has formed key alliances to advance its products: a strategic collaboration with Medtronic focuses on developing and commercializing BackBeat CNT for pacemaker-indicated patients suffering from hypertension. Additionally, a partnership with Terumo...[Read more]

Industry

Biotechnology

IPO Date

2020-08-04

Stock Exchange

NASDAQ

Ticker

OBIO

The ROE as of June 2026 (TTM) for Orchestra BioMed Holdings, Inc. (OBIO) is -137.99%

According to Orchestra BioMed Holdings, Inc.’s latest financial reports and current stock price. The company's current ROE is -137.99%. This represents a change of -91.69% compared to the average of -1660.52% of the last 4 quarters.

Orchestra BioMed Holdings, Inc. (OBIO) Historical ROE (quarterly & annually)

How has OBIO ROE performed in the past?

The mean historical ROE of Orchestra BioMed Holdings, Inc. over the last ten years is -54.70%. The current -137.99% ROE has changed 152.29% with respect to the historical average. Over the past ten years (40 quarters), OBIO's ROE was at its highest in in the December 2021 quarter at 11.32%. The ROE was at its lowest in in the March 2022 quarter at -7344.87%.

Quarterly (TTM)
Annual

Average

-54.70%

Median

-68.08%

Minimum

-185.16%

Maximum

43.99%

Orchestra BioMed Holdings, Inc. (OBIO) ROE by Quarter and Year

Discovering the peaks and valleys of Orchestra BioMed Holdings, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 156.49%

Maximum Annual ROE = 43.99%

Minimum Annual Increase = -298.01%

Minimum Annual ROE = -185.16%

Quarterly (TTM)
Annual
YearROEChange
2025-83.15%-55.09%
2024-185.16%156.49%
2023-72.19%12.84%
2022-63.97%-298.01%
202132.31%-26.56%

Orchestra BioMed Holdings, Inc. (OBIO) Average ROE

How has OBIO ROE performed in the past?

The current ROE of Orchestra BioMed Holdings, Inc. (OBIO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-113.50%

5-year avg

-74.43%

10-year avg

-54.70%

Orchestra BioMed Holdings, Inc. (OBIO) ROE vs. Peers

How is OBIO’s ROE compared to its peers?

Orchestra BioMed Holdings, Inc.’s ROE is greater than Prelude Therapeutics Incorporated (-118.24%), less than Inventiva S.A. (1.87%), greater than Caribou Biosciences, Inc. (-100.13%), greater than Enanta Pharmaceuticals, Inc. (-64.04%), greater than Invivyd, Inc. (-53.48%), greater than Pyxis Oncology, Inc. (-135.60%), greater than Protara Therapeutics, Inc. (-38.70%), greater than Tenaya Therapeutics, Inc. (-80.56%), greater than Eupraxia Pharmaceuticals Inc. (-50.81%), greater than Avalo Therapeutics, Inc. (-97.55%),

Build a custom stock screener for Orchestra BioMed Holdings, Inc. (OBIO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Orchestra BioMed Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Orchestra BioMed Holdings, Inc. (OBIO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Orchestra BioMed Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Orchestra BioMed Holdings, Inc.'s ROE?

How is the ROE calculated for Orchestra BioMed Holdings, Inc. (OBIO)?

What is the highest ROE for Orchestra BioMed Holdings, Inc. (OBIO)?

What is the 3-year average ROE for Orchestra BioMed Holdings, Inc. (OBIO)?

What is the 5-year average ROE for Orchestra BioMed Holdings, Inc. (OBIO)?

How does the current ROE for Orchestra BioMed Holdings, Inc. (OBIO) compare to its historical average?